Genetic and antigenic diversity of human rotaviruses: potential impact on vaccination programs.
about
Rotavirus diversity and evolution in the post-vaccine worldWhole genome analysis of selected human and animal rotaviruses identified in Uganda from 2012 to 2014 reveals complex genome reassortment events between human, bovine, caprine and porcine strains.IgY antibodies protect against human Rotavirus induced diarrhea in the neonatal gnotobiotic piglet disease model.The impact of Rotavirus mass vaccination on hospitalization rates, nosocomial Rotavirus gastroenteritis and secondary blood stream infectionsRecombinant monovalent llama-derived antibody fragments (VHH) to rotavirus VP6 protect neonatal gnotobiotic piglets against human rotavirus-induced diarrhea.Whole genome detection of rotavirus mixed infections in human, porcine and bovine samples co-infected with various rotavirus strains collected from sub-Saharan AfricaDecline in rotavirus hospitalizations following the first three years of vaccination in Castile-La Mancha, Spain.Genome-Wide Evolutionary Analyses of G1P[8] Strains Isolated Before and After Rotavirus Vaccine Introduction.Surveillance and molecular characterization of group A rotaviruses in Goroka, Papua New Guinea.Full-genome characterization of a G8P[8] rotavirus that emerged among children with diarrhea in Croatia in 2006Rice-based oral antibody fragment prophylaxis and therapy against rotavirus infection.Circulation of group A rotaviruses among neonates of human, cow and pig: study from Assam, a north eastern state of IndiaNew approaches in oral rotavirus vaccines.Design and Construction of Chimeric VP8-S2 Antigen for Bovine Rotavirus and Bovine Coronavirus.Pathogen-induced secretory diarrhea and its prevention.Molecular epidemiology and surveillance of circulating rotavirus and adenovirus in Congolese children with gastroenteritis.Surveillance of rotavirus gastro-enteritis in children in Blantyre, Malawi.Identification of vaccine-derived rotavirus strains in children with acute gastroenteritis in Japan, 2012-2015.Strengthening laboratory capacity through the surveillance of rotavirus gastroenteritis in Central Africa: the Surveillance Épidémiologique en Afrique Centrale (SURVAC) Project.Rotavirus specific maternal antibodies and immune response to RV3-BB neonatal rotavirus vaccine in New Zealand.High Diversity of Genogroup I Picobirnaviruses in Mammals.Investigation of Rotavirus with Various Methods in Children with Acute Gastroenteritis and Determination of Its Molecular Epidemiology in Kayseri Province, Turkey.Rotavirus vaccine stability in the aquatic environment.Comparative In Vitro and In Vivo Studies of Porcine Rotavirus G9P[13] and Human Rotavirus Wa G1P[8].The effect of bovine rotavirus and its nonstructural protein 4 on ER stress-mediated apoptosis in HeLa and HT-29 cells.Unexpected spreading of G12P[8] rotavirus strains among young children in a small area of central Italy.Rotavirus genotypes in children in the community with diarrhea in Madagascar.Whole genome analyses of G1P[8] rotavirus strains from vaccinated and non-vaccinated South African children presenting with diarrhea.Evidence of VP7 and VP4 intra-lineage diversification in G4P[8] Italian human rotaviruses.Characterization of the NSP4 gene of group A human rotavirus G1P[8] strains circulating in Sapporo, Japan from 1987 to 2000.Rotavirus virus-like particles (RV-VLPs) vaccines: An update.Full genomic analysis of G1P[8] rotavirus strains recovered from rotavirus vaccinated and non-vaccinated children hospitalized for acute gastroenteritis in Pune, western India.Prevalence of human rotavirus genotypes in Wuhan, China, during 2008-2011: changing trend of predominant genotypes and emergence of strains with the P[8]b subtype of the VP4 gene
P2860
Q24632674-241531EF-9E50-4F8A-B950-91FB8BB63540Q33825247-DB5317C0-A756-4978-81A0-30619C0C4719Q34374741-DEF95704-F52F-40E3-9A48-63A6C6573A00Q34604662-CEA81C7B-504C-4500-BC3B-D3D595E0735DQ34711833-D8B6685B-00E5-40B3-9050-E49CBD8C2155Q35181316-02FDE9D9-0625-4FD3-A8CE-DD431FE895E8Q35886862-9CBA7B3E-93E3-4F99-B242-93C0E7C8087AQ36166655-08A5C807-743C-4352-A883-EFA84755E9D3Q36450198-213BAD3A-1C34-476F-BF28-EA620C664E44Q36826628-20543B1C-831E-45A9-AEA6-394198EC06ECQ37123967-91A8F662-9E73-4142-9C66-628B0569FAB6Q37201741-B9F14C2D-54C0-4291-9146-4C4D34A30594Q38255552-D63233D0-69A0-4123-A8EB-00B9C1CD3780Q38874728-88F4070A-CCDF-49C6-8D8F-2CCCE7AA4BC4Q38912737-39F764FE-CBBE-42B7-944E-C44DF239BD09Q39228606-C15DDA73-2B82-4A87-850E-71A4ECE6F4F6Q39452622-AA130159-A4FE-47C3-920E-F783F1B04514Q40048931-B623CA94-1AB9-4FAE-89E4-DFE9B9B78B36Q40368238-6ED621F9-7F25-4C33-BA7C-BF84592815E6Q40393201-BD3B4913-C318-4417-948B-88E852FAF777Q40417194-E37CF899-26B2-4BDF-AF14-22705A4328EBQ40601917-C920757C-2F79-4B71-AB8D-BAC91941F0E3Q40873450-692299E1-4143-470E-A289-7FD3A5A94606Q40952104-3915BE98-1D7C-4DF0-80A5-FAF4FAC4076CQ40970538-1AD508C8-610D-46E9-A02A-9E043735A117Q41251470-DF5AC899-E20E-4447-9195-4AEC8B69F4F8Q41396305-00215B19-118D-42FC-A72C-5F8C5F4D7A59Q42217823-91238463-250F-41A0-8E49-A16F95FC2CB9Q42248167-F900F747-6E7F-4332-83F9-601C399B3878Q42270389-03B24989-8C1F-4E69-8416-E5772C606AE0Q45326050-44481295-E1AE-42CC-B349-7D2381B2F747Q47304176-0FD0E769-3C8B-4B35-B978-096F03AD54E6Q58813658-D4A93C2E-1474-436F-8505-89362C10F17A
P2860
Genetic and antigenic diversity of human rotaviruses: potential impact on vaccination programs.
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Genetic and antigenic diversit ...... mpact on vaccination programs.
@ast
Genetic and antigenic diversit ...... mpact on vaccination programs.
@en
Genetic and antigenic diversit ...... mpact on vaccination programs.
@nl
type
label
Genetic and antigenic diversit ...... mpact on vaccination programs.
@ast
Genetic and antigenic diversit ...... mpact on vaccination programs.
@en
Genetic and antigenic diversit ...... mpact on vaccination programs.
@nl
prefLabel
Genetic and antigenic diversit ...... mpact on vaccination programs.
@ast
Genetic and antigenic diversit ...... mpact on vaccination programs.
@en
Genetic and antigenic diversit ...... mpact on vaccination programs.
@nl
P356
P1476
Genetic and antigenic diversit ...... mpact on vaccination programs.
@en
P2093
Carl D Kirkwood
P356
10.1086/653548
P407
P478
P577
2010-09-01T00:00:00Z